EUVIMEDEUVIMED entdecken
Crossref

PRMT6 Inhibits Malignant Progression of Melanoma by Antagonizing Trimethylation of Histone H3K4 to Downregulate ALDH1A1 Levels

Man Cai, Liangyu Wang iD, Miao Sun iD, Meixi Liu, Yingchun Liu

Pigment Cell & Melanoma Research · 2025

DOI: 10.1111/pcmr.70034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pigment Cell & Melanoma Research, 2025. Verfasst von Man Cai und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, General Hospital of Northern Theater Command, Shenyang, China. Hauptthemen laut MEDLINE: Protein-Arginine N-Methyltransferases, Melanoma, Histones, Down-Regulation. Die Arbeit nennt 46 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Protein arginine methyltransferase 6 (PRMT6), a member of the PRMT family capable of self‐arginine methylation, is down‐regulated in melanoma, but the specific mechanism is still unclear. Our work demonstrated that PRMT6 overexpression significantly inhibited the ability of melanoma cells to proliferate, tumorigenicity, migration, and invasion, whereas PRMT6 knockdown rescued these malignant behaviors of melanoma cells. Mechanistically, we identified aldehyde dehydrogenase 1A1 (ALDH1A1) as a critical downstream target of PRMT6. PRMT6 knockdown up‐regulated ALDH1A1 expression, exacerbating melanoma aggressiveness in vitro. Further investigations revealed that PRMT6 modulates ALDH1A1 expression by catalyzing asymmetric dimethylation of histone H3 at arginine 2 (H3R2me2a) and antagonizing the enrichment of histone H3 lysine 4 trimethylation (H3K4me3) at the ALDH1A1 promoter. In addition, dual‐luciferase experiments showed that the transcription factor KLF4 may bind to the −1800 ~ +45 sequence of PRMT6, thereby negatively regulating PRMT6 expression in melanoma. Our findings underscore the tumor‐suppressive role of PRMT6 in melanoma pathogenesis, highlighting its potential as a novel therapeutic target, particularly for metastatic melanoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein-Arginine N-MethyltransferasesMelanomaHistonesDown-RegulationRetinal DehydrogenaseDisease ProgressionHumansMethylationAldehyde Dehydrogenase 1 FamilyCell Line, TumorGene Expression Regulation, NeoplasticKruppel-Like Factor 4AnimalsCell ProliferationCell MovementMicePromoter Regions, GeneticKruppel-Like Transcription FactorsNeoplasm InvasivenessNuclear Proteins

Stichwörter der Autor:innen

ALDH1A1KLF4PRMT6melanoma

Substanzen

Protein-Arginine N-MethyltransferasesHistonesAldehyde Dehydrogenase 1 FamilyRetinal DehydrogenaseALDH1A1 protein, humanPRMT6 protein, humanKruppel-Like Factor 4KLF4 protein, humanKlf4 protein, mousehistone H3 trimethyl Lys4

Autor:innen und Institutionen

  • Department of Dermatology, General Hospital of Northern Theater Command, Shenyang, China.
  • Department of Neurology, General Hospital of Northern Theater Command, Shenyang, China.

ORCID-Profile: Liangyu Wang, Miao Sun

Zitieren

APA

Cai, M., Wang, L., Sun, M., Liu, M., & Liu, Y. (2025). PRMT6 Inhibits Malignant Progression of Melanoma by Antagonizing Trimethylation of Histone H3K4 to Downregulate ALDH1A1 Levels. Pigment Cell & Melanoma Research. https://doi.org/10.1111/pcmr.70034

Vancouver

Cai M, Wang L, Sun M, Liu M, Liu Y. PRMT6 Inhibits Malignant Progression of Melanoma by Antagonizing Trimethylation of Histone H3K4 to Downregulate ALDH1A1 Levels. Pigment Cell & Melanoma Research. 2025. doi:10.1111/pcmr.70034

BibTeX
@article{Cai2025,
  author = {Cai, Man and Wang, Liangyu and Sun, Miao and Liu, Meixi and Liu, Yingchun},
  title = {PRMT6 Inhibits Malignant Progression of Melanoma by Antagonizing Trimethylation of Histone H3K4 to Downregulate ALDH1A1 Levels},
  journal = {Pigment Cell & Melanoma Research},
  year = {2025},
  doi = {10.1111/pcmr.70034}
}
Kostenlos starten →